PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients

NCT01373684 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Nucleos(t)ide analogue

Sponsor

Foundation for Liver Research

Collaborators

[object Object]